4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-16-147288
Chief Legal Officer sold 3,912 shares at $21.83 ($85,399)
- Chief Legal Officer acquired 3,912 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ali-Jackson Kamil Chief Legal Officer | 2016-10-26 | Option exercise | +3,912 | $1.52 | $5,946 | 79,869 | D |
| Ali-Jackson Kamil Chief Legal Officer | 2016-10-26 | Sale | −3,912 | $21.83 | $85,399 | 75,957 | D |
| Derivatives | |||||||
| Ali-Jackson Kamil Chief Legal Officer | 2016-10-26 | Option exercise · Employee StockOption (right to buy) | −3,912 | 6,522 | D | ||
| Open-market sales · 3,912 sh · avg $21.83 · $85,399 | |||||||
Loading xslF345X03/doc4.xml…